Skip to main content
PMC home page
The BMJ logoLink to The BMJ
editorial
. 1995 Sep 16;311(7007):701–702. doi: 10.1136/bmj.311.7007.701

To beta block or better block?

M J Brown
PMCID: PMC2550713  PMID: 7549675

Full text

PDF
701

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brodde O. E. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev. 1991 Jun;43(2):203–242. [PubMed] [Google Scholar]
  2. Brown M. J., Allison D. J., Jenner D. A., Lewis P. J., Dollery C. T. Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet. 1981 Jan 24;1(8213):174–177. doi: 10.1016/s0140-6736(81)90058-1. [DOI] [PubMed] [Google Scholar]
  3. Brown M. J., Brown D. C., Murphy M. B. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983 Dec 8;309(23):1414–1419. doi: 10.1056/NEJM198312083092303. [DOI] [PubMed] [Google Scholar]
  4. Brown M. J. What do beta-blockers really do? A view from both sides of the receptor. Based on the Oliver Sharpey Lecture 1992. J R Coll Physicians Lond. 1993 Oct;27(4):420–427. [PMC free article] [PubMed] [Google Scholar]
  5. Cleophas T. J., Kauw F. H. More on paradoxical pressor effects of nonselective beta-blockers. Circulation. 1994 Oct;90(4):2157–2159. doi: 10.1161/01.cir.90.4.2157. [DOI] [PubMed] [Google Scholar]
  6. Clutter W. E., Bier D. M., Shah S. D., Cryer P. E. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest. 1980 Jul;66(1):94–101. doi: 10.1172/JCI109840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drayer J. I., Keim H. J., Weber M. A., Case D. B., Laragh J. H. Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity. Am J Med. 1976 May 31;60(6):897–903. doi: 10.1016/0002-9343(76)90911-6. [DOI] [PubMed] [Google Scholar]
  8. Ferro A., Kaumann A. J., Brown M. J. Beta 1- and beta 2-adrenoceptor-mediated relaxation in human internal mammary artery and saphenous vein: unchanged beta- and alpha-adrenoceptor responsiveness after chronic beta 1-adrenoceptor blockade. Br J Pharmacol. 1993 Aug;109(4):1053–1058. doi: 10.1111/j.1476-5381.1993.tb13728.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hall J. A., Kaumann A. J., Brown M. J. Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium. Circ Res. 1990 Jun;66(6):1610–1623. doi: 10.1161/01.res.66.6.1610. [DOI] [PubMed] [Google Scholar]
  10. Hall J. A., Petch M. C., Brown M. J. In vivo demonstration of cardiac beta 2-adrenoreceptor sensitization by beta 1-antagonist treatment. Circ Res. 1991 Oct;69(4):959–964. doi: 10.1161/01.res.69.4.959. [DOI] [PubMed] [Google Scholar]
  11. Hall J. A., Petch M. C., Brown M. J. Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart. Circ Res. 1989 Sep;65(3):546–553. doi: 10.1161/01.res.65.3.546. [DOI] [PubMed] [Google Scholar]
  12. Karlsberg R. P., Cryer P. E., Roberts R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J. 1981 Jul;102(1):24–29. doi: 10.1016/0002-8703(81)90408-7. [DOI] [PubMed] [Google Scholar]
  13. Struthers A. D., Reid J. L., Whitesmith R., Rodger J. C. The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci (Lond) 1983 Aug;65(2):143–147. doi: 10.1042/cs0650143. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES